We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
(-43%)
Cap. Flow
-$786M
Cap. Flow
% of AUM
-52.7%
Top 10 Holdings %
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$10.5M |
| 2 |
iShares MSCI India ETF
INDA
|
+$9.67M |
| 3 |
IBKC
IBERIABANK Corp
IBKC
|
+$8.93M |
| 4 |
BlackRock Corporate High Yield Fund
HYT
|
+$8.03M |
| 5 |
Amazon
AMZN
|
+$7.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$16.7M |
| 2 |
Netflix
NFLX
|
+$15.8M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$15.7M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$15.1M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.31% |
| 2 | Consumer Discretionary | 3.94% |
| 3 | Healthcare | 3.91% |
| 4 | Communication Services | 2.7% |
| 5 | Financials | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Evergy
EVRG
$18.9B
| $6K | ﹤0.01% |
+104
| New | +$6.83K |
|
1202
Helmerich & Payne
HP
$4.25B
| $6K | ﹤0.01% |
356
-2,323
| -87% | -$81.8K |
|
1203
Hyster-Yale Materials Handling
HY
$619M
| $6K | ﹤0.01% |
162
-838
| -84% | -$42.2K |
|
1204
PUT
Inovio Pharmaceuticals
INO
$79.1M
| $6K | ﹤0.01% |
+67
| New | +$4.13K |
|
1205
CALL
Macy's
M
$6.45B
| $6K | ﹤0.01% |
1,300
-8,300
| -86% | -$113K |
|
1206
Marcus Corp
MCS
$884M
| $6K | ﹤0.01% |
524
-76
| -13% | -$1.91K |
|
1207
CALL
MetLife
MET
$61.5B
| $6K | ﹤0.01% |
200
-49,800
| -100% | -$2.21M |
|
1208
NACCO Industries
NC
$306M
| $6K | ﹤0.01% |
200
-528
| -73% | -$21.7K |
|
1209
Par Pacific Holdings
PARR
$3.78B
| $6K | ﹤0.01% |
900
-600
| -40% | -$10K |
|
1210
Spero Therapeutics
SPRO
$71.2M
| $6K | ﹤0.01% |
700
-200
| -22% | -$1.76K |
|
1211
CALL
Wells Fargo
WFC
$264B
| $6K | ﹤0.01% |
200
-1,000
| -83% | -$42.5K |
|
1212
CALL
AdvisorShares Pure Cannabis ETF
YOLO
$33.2M
| $6K | ﹤0.01% |
+800
| New | +$8.17K |
|
|
SUM
1213
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $6K | ﹤0.01% |
+407
| New | +$7.91K |
|
|
PDCE
1214
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $6K | ﹤0.01% |
+1,000
| New | +$18K |
|
|
DBD
1215
DELISTED
Diebold Nixdorf Incorporated
DBD
| $6K | ﹤0.01% |
1,642
-997
| -38% | -$8.44K |
|
|
CUB
1216
DELISTED
Cubic Corporation
CUB
| $6K | ﹤0.01% |
153
-630
| -80% | -$36.4K |
|
1217
Allient
ALNT
$1.94B
| $5K | ﹤0.01% |
300
-22,860
| -99% | -$615K |
|
1218
Alpha and Omega Semiconductor
AOSL
$1.04B
| $5K | ﹤0.01% |
727
-4,673
| -87% | -$50.8K |
|
1219
CALL
Evolus
EOLS
$551M
| $5K | ﹤0.01% |
1,200
+400
| +50% | +$3.39K |
|
1220
Genpact
G
$5.71B
| $5K | ﹤0.01% |
+163
| New | +$6.38K |
|
1221
Global Payments
GPN
$22.7B
| $5K | ﹤0.01% |
+37
| New | +$6.76K |
|
1222
CALL
iShares Gold Trust
IAU
$64.8B
| $5K | ﹤0.01% |
+150
| New | +$4.54K |
|
1223
Kinder Morgan
KMI
$70.1B
| $5K | ﹤0.01% |
337
-259
| -43% | -$4.93K |
|
1224
PUT
Live Nation Entertainment
LYV
$42.7B
| $5K | ﹤0.01% |
+100
| New | +$6.18K |
|
1225
CALL
Novavax
NVAX
$1.31B
| $5K | ﹤0.01% |
+400
| New | +$3.38K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
CC
MB
ACM
Prelude Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.
- Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
- Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
- Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
- Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
- Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
- Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
- Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.
Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.